Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

NSUN7 Inhibitors

The chemical class denoted as NSUN7 Inhibitors encompasses various compounds that target or have the potential to modulate the activity of the NSUN7 protein, an RNA methyltransferase. The exact signaling pathways and comprehensive functionality of NSUN7 are yet to be extensively detailed. However, based on its classification, it's understood that NSUN7 is likely involved in the methylation of cytosine residues within RNA.

Given its functional profile, chemicals such as sinefungin, a potent AdoMet analog, can reduce RNA methylation events by competing with the natural methyl donor AdoMet. On a similar note, adenosine periodate acts by oxidizing adenosine in RNA, subsequently altering the structure and the substrate availability for RNA methyltransferases like NSUN7. Additionally, compounds like 5-Aza-2'-deoxycytidine, RG108, and Decitabine, primarily known for their DNA methyltransferase inhibitory properties, could indirectly influence RNA methylation, hinting at a possible modulatory role on NSUN7. Furthermore, amiloride and amodiaquine, although not exclusive to RNA methyltransferases, showcase inhibitory actions under certain contexts. Overall, the collective actions of these chemicals emphasize the intricate nature of RNA methylation processes and offer a framework for understanding the modulation of NSUN7's function within the cellular environmen

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Adenosine, periodate oxidized

34240-05-6sc-214510
sc-214510A
25 mg
100 mg
$117.00
$357.00
(0)

Alters RNA structure by oxidizing adenosine. The changed RNA structure can influence the substrate availability for RNA methyltransferases, including NSUN7.

Sinefungin

58944-73-3sc-203263
sc-203263B
sc-203263C
sc-203263A
1 mg
100 mg
1 g
10 mg
$266.00
$5100.00
$39576.00
$690.00
4
(1)

AdoMet analog that inhibits various methyltransferases. By competing with the methyl donor AdoMet, sinefungin can reduce methylation events on RNA, potentially affecting NSUN7 activity.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

A cytosine analog that incorporates into DNA/RNA and inhibits DNA methyltransferases. It may indirectly affect RNA methylation and NSUN7.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

DNA methyltransferase inhibitor that can indirectly influence the state of RNA methylation by affecting the methylation status of DNA and potentially modulating NSUN7 activity.

SANT-1

304909-07-7sc-203253
5 mg
$132.00
5
(0)

EZH2 inhibitor that targets histone methylation but may have off-target effects on RNA methyltransferases, including NSUN7.

Amiloride

2609-46-3sc-337527
1 g
$290.00
7
(1)

Known to inhibit RNA methyltransferase activity in some contexts, possibly modulating NSUN7's methylation events.

5′-Deoxy-5′-methylthioadenosine

2457-80-9sc-202427
50 mg
$120.00
1
(1)

A natural byproduct of polyamine biosynthesis which can inhibit methyltransferase enzymes, potentially influencing NSUN7 activity.

Amodiaquine

86-42-0sc-207282
10 mg
$342.00
1
(1)

Antimalarial drug found to inhibit RNA methyltransferases in some conditions. Might modulate NSUN7's enzymatic activity.

Procainamide hydrochloride

614-39-1sc-202297
10 g
$52.00
(1)

Non-nucleoside inhibitor of DNA methyltransferases. Its role in RNA methylation is less clear, but it might indirectly modulate NSUN7.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$126.00
$278.00
$984.00
3
(1)

DNA methyltransferase inhibitor that, through altering DNA methylation dynamics, may indirectly impact RNA methylation status and NSUN7 function.